The Claim
Inositol hexaphosphate (IP6) supplementation at 600 mg twice daily for two weeks reduces fasting serum uric acid levels in asymptomatic hyperuricemic adults with baseline serum uric acid levels between 7.0 and 9.0 mg/dL.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 600 mg of inositol hexaphosphate twice daily for two weeks lowers fasting uric acid levels in adults with elevated uric acid but no symptoms of gout or kidney disease.
See the scientific wording
Inositol hexaphosphate (IP6) supplementation at 600 mg twice daily for two weeks reduces fasting serum uric acid in asymptomatic hyperuricemic adults with baseline levels between 7.0 and 9.0 mg/dL, but its effects on clinical outcomes such as gout or kidney disease remain unestablished.
When IP6 is taken by mouth, it binds to purine molecules in the gut, preventing them from being absorbed into the bloodstream. With fewer purines reaching the liver, less uric acid is made, which lowers the amount in the blood.
What the research says
1 studyThis study found that taking IP6 supplements twice a day for two weeks lowered uric acid levels in the blood of people with high levels, just like the claim says. But it didn’t check if this helps prevent gout or kidney problems, so that part is still unknown.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.